254 related articles for article (PubMed ID: 9372062)
1. Orally active iron chelators in the treatment of iron overload.
Olivieri NF
Curr Opin Hematol; 1996 Mar; 3(2):125-30. PubMed ID: 9372062
[TBL] [Abstract][Full Text] [Related]
2. Long-term therapy with deferiprone.
Olivieri NF
Acta Haematol; 1996; 95(1):37-48. PubMed ID: 8604585
[TBL] [Abstract][Full Text] [Related]
3. Oral deferiprone for iron chelation in people with thalassaemia.
Fisher SA; Brunskill SJ; Doree C; Chowdhury O; Gooding S; Roberts DJ
Cochrane Database Syst Rev; 2013 Aug; (8):CD004839. PubMed ID: 23966105
[TBL] [Abstract][Full Text] [Related]
4. A randomized, placebo-controlled, double-blind trial of the effect of combined therapy with deferoxamine and deferiprone on myocardial iron in thalassemia major using cardiovascular magnetic resonance.
Tanner MA; Galanello R; Dessi C; Smith GC; Westwood MA; Agus A; Roughton M; Assomull R; Nair SV; Walker JM; Pennell DJ
Circulation; 2007 Apr; 115(14):1876-84. PubMed ID: 17372174
[TBL] [Abstract][Full Text] [Related]
5. Comparison between deferoxamine and deferiprone (L1) in iron-loaded thalassemia patients.
Taher A; Sheikh-Taha M; Koussa S; Inati A; Neeman R; Mourad F
Eur J Haematol; 2001 Jul; 67(1):30-4. PubMed ID: 11553264
[TBL] [Abstract][Full Text] [Related]
6. Long term deferiprone chelation therapy.
Hoffbrand VA; Wonke B
Adv Exp Med Biol; 2002; 509():127-39. PubMed ID: 12572992
[No Abstract] [Full Text] [Related]
7. Pharmacotherapy of iron overload in thalassaemic patients.
Ceci A; Felisi M; De Sanctis V; De Mattia D
Expert Opin Pharmacother; 2003 Oct; 4(10):1763-74. PubMed ID: 14521486
[TBL] [Abstract][Full Text] [Related]
8. Deferiprone: second-line treatment of iron overload in the absence of a better alternative.
Prescrire Int; 2007 Oct; 16(91):196. PubMed ID: 17926834
[TBL] [Abstract][Full Text] [Related]
9. Oral deferiprone for iron chelation in people with thalassaemia.
Roberts DJ; Brunskill SJ; Doree C; Williams S; Howard J; Hyde CJ
Cochrane Database Syst Rev; 2007 Jul; (3):CD004839. PubMed ID: 17636775
[TBL] [Abstract][Full Text] [Related]
10. [Iron chelation in 1998].
de Montalembert M
Transfus Clin Biol; 1998 Oct; 5(5):353-6. PubMed ID: 9836396
[TBL] [Abstract][Full Text] [Related]
11. Deferiprone: New insight.
Piga A; Roggero S; Vinciguerra T; Sacchetti L; Gallo V; Longo F
Ann N Y Acad Sci; 2005; 1054():169-74. PubMed ID: 16339662
[TBL] [Abstract][Full Text] [Related]
12. Deferiprone: a review of its clinical potential in iron overload in beta-thalassaemia major and other transfusion-dependent diseases.
Barman Balfour JA; Foster RH
Drugs; 1999 Sep; 58(3):553-78. PubMed ID: 10493280
[TBL] [Abstract][Full Text] [Related]
13. Deferiprone: new preparation. Poorly assessed.
Prescrire Int; 2000 Oct; 9(49):131-5. PubMed ID: 11603411
[TBL] [Abstract][Full Text] [Related]
14. Transfusional iron overload and chelation therapy with deferoxamine and deferiprone (L1).
Kontoghiorghes GJ; Pattichi K; Hadjigavriel M; Kolnagou A
Transfus Sci; 2000 Dec; 23(3):211-23. PubMed ID: 11099897
[TBL] [Abstract][Full Text] [Related]
15. Iron-chelation therapy with oral deferiprone in patients with thalassemia major.
Olivieri NF; Brittenham GM; Matsui D; Berkovitch M; Blendis LM; Cameron RG; McClelland RA; Liu PP; Templeton DM; Koren G
N Engl J Med; 1995 Apr; 332(14):918-22. PubMed ID: 7877649
[TBL] [Abstract][Full Text] [Related]
16. The controversial role of deferiprone in the treatment of thalassemia.
Richardson DR
J Lab Clin Med; 2001 May; 137(5):324-9. PubMed ID: 11329529
[TBL] [Abstract][Full Text] [Related]
17. A multi-center safety trial of the oral iron chelator deferiprone.
Cohen A; Galanello R; Piga A; Vullo C; Tricta F
Ann N Y Acad Sci; 1998 Jun; 850():223-6. PubMed ID: 9668543
[TBL] [Abstract][Full Text] [Related]
18. Deferiprone versus deferoxamine in thalassemia intermedia: Results from a 5-year long-term Italian multicenter randomized clinical trial.
Calvaruso G; Vitrano A; Di Maggio R; Lai E; Colletta G; Quota A; Gerardi C; Rigoli LC; Sacco M; Pitrolo L; Maggio A
Am J Hematol; 2015 Jul; 90(7):634-8. PubMed ID: 25809173
[TBL] [Abstract][Full Text] [Related]
19. Combined therapy with deferoxamine and deferiprone.
Kattamis A
Ann N Y Acad Sci; 2005; 1054():175-82. PubMed ID: 16339663
[TBL] [Abstract][Full Text] [Related]
20. Deferiprone-induced agranulocytosis: 20 years of clinical observations.
Tricta F; Uetrecht J; Galanello R; Connelly J; Rozova A; Spino M; Palmblad J
Am J Hematol; 2016 Oct; 91(10):1026-31. PubMed ID: 27415835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
